Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Nature Portfolio, 2021.
    • الموضوع:
      2021
    • Collection:
      LCC:Science
    • نبذة مختصرة :
      Here the authors report the results of randomized, single-blind, placebocontrolled trial on the effects of a asingle subcutaneous dose of Peginterferon Lambda-1a (Lambda) in 120 outpatients with mild to moderate COVID-19, showing that while treatment is well tolerated it does not shorten the duration of SARS-CoV-2 viral shedding nor improves symptoms.
    • File Description:
      electronic resource
    • ISSN:
      2041-1723
    • Relation:
      https://doaj.org/toc/2041-1723
    • الرقم المعرف:
      10.1038/s41467-021-22177-1
    • الرقم المعرف:
      edsdoj.5fbb6d030f594c858730d7fccbf367da